DKDebasish Kar

Debasish Kar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Debasish Kar has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Enzymatic Degradation of Pollutants

    by Gaurisha Tripathi, Aliza Irfan, Gauri Raj, Debasish Kar


  • Open Access

    Biomass Sources for Energy Generation—Biofuel Production and Biorefineries

    by Avani Ghodke, Pronkita Mitra, Debasish Kar

    Our planet’s growing energy needs and the harsh environmental impact of fossil fuels demand urgent, sustainable energy solutions. While biomass offers a promising path to reduce carbon footprints, its broad adoption faces significant hurdles, including competition for food sources, high processing costs, and various technological challenges. To tackle these critical limitations, a comprehensive exploration delves into biomass-based energy generation, biofuel production, and the vital role of biorefineries in fostering a circular bioeconomy, to highlight pathways for improved efficiency and economic viability. Key insights include a categorization of biomass feedstocks into four distinct generations and a detailed look at a wide array of versatile production techniques—from fermentation to pyrolysis—that convert biomass into diverse fuels. We underscore the pivotal role of biorefineries in maximizing biomass utilization and minimizing waste and spotlight recent breakthroughs in biotechnology, catalysts, and biorefinery operations that are actively making biomass energy more efficient and affordable. Ultimately, we stress the critical importance of strong policy support, increased research investment, and ongoing technological innovations to truly scale biomass energy and secure a sustainable energy future.

  • Open Access

    Physiological Impact of Milk on Multiple Health Outcomes in Human

    by Upama Majumder, Samayeta Pramanik, Mobasshara Uzma, Kavya P R, Debasish Kar

    Milk is best known as a nutrient-rich fluid produced by the mammary glands of mammals, designed primarily to feed young. In the human diet, cow milk is most prevalent, but milk of other mammals and plant milk are common too. This study aims to investigate milk's nutritional value in various age groups and review opposing evidence of its effect on cardiovascular diseases in adults. It is a literature-based strategy to synthesize information from observational and meta-analytic studies. The milk content—macronutrients, vitamins, minerals—was compared to its role in maintaining growth, development, and well-being. In addition, evidence was reviewed on milk intake during adulthood and its link to cardiovascular wellness to assess risk relationships. Milk is rich in good-quality proteins, essential fatty acids, vitamins (A, D, B12), and minerals (calcium, phosphorus), beneficial for immune function, bone health, hydration, and weight control. Infants and children particularly gain advantage from its complete nutrient profile, while in adults, it contributes to muscle repair and cardiovascular health. Evidence regarding milk's role in cardiovascular disease (CVD) is contradictory. Some find a protective effect, while others report increased risk. Interestingly, a meta-analysis of prospective trials found that a daily consumption of 200 mL of milk was associated with a statistically significant reduction of CVD risk, even when whole milk was consumed. Milk remains an integral part of human nutrition due to its high nutrient content. Nonetheless, incongruent outcomes of its contribution to cardiovascular morbidity necessitate personalized dietary instructions. Further work should elucidate mechanisms for incongruent observations and provide concrete recommendations for milk intake for different ages and diseases.


  • Open Access

    The evolving battle against resistance: from phage therapy to prediction, establishing a sustainable strategy against AMR

    by Varshaa Arer, Debasish Kar

    The biggest threat to global health, which claims 700,000 lives annually, is the appearance and quick spread of multidrug resistant diseases. The mortality rate is anticipated to rise in the following decade owing to the escalating issue of antibiotic resistance. This resistance is due to the misuse and overuse of antibiotics, allowing infectious bacteria to evolve resistance that makes treatments ineffective. Phage therapy, long buried by an antibiotic era, is enjoying a well-deserved renaissance as a consequence of the increase in antibiotic resistance leading to a variety of illnesses that are remediless. This rising concern has made the scientific body more cautious about developing an approach without considering its implications. While establishing an alternative therapy, numerous factors must be taken into account, including the relative benefits and drawbacks. Bacteriophages provide unique insight into the generation of innovative medicines that will lower the frequency of bacterial illnesses since they are host-specific. As the globe transitions away from the widespread use of antibiotics, this review describes the prospective utility, strategies, recent developments, and clinical studies of phage therapy while also highlighting contemporary treatments for MDR bacteria.


  • Open Access

    The Molecular Basis of Wnt/β-Catenin Signaling Pathways in Neurodegenerative Diseases

    by Ananya Anurag Anand, Misbah Khan, Monica V, Debasish Kar

    Defective Wnt signaling is found to be associated with various neurodegenerative diseases. In the canonical pathway, the Frizzled receptor (Fzd) and the lipoprotein receptor-related proteins 5/6 (LRP5/LRP6) create a seven-pass transmembrane receptor complex to which the Wnt ligands bind. This interaction causes the tumor suppressor adenomatous polyposis coli gene product (APC), casein kinase 1 (CK1), and GSK-3β (glycogen synthase kinase-3 beta) to be recruited by the scaffold protein Dishevelled (Dvl), which in turn deactivates the β-catenin destruction complex. This inactivation stops the destruction complex from phosphorylating β-catenin. As a result, β-catenin first builds up in the cytoplasm and then migrates into the nucleus, where it binds to the Lef/Tcf transcription factor to activate the transcription of more than 50 Wnt target genes, including those involved in cell growth, survival, differentiation, neurogenesis, and inflammation. The treatments that are currently available for neurodegenerative illnesses are most commonly not curative in nature but are only symptomatic. According to all available research, restoring Wnt/β-catenin signaling in the brains of patients with neurodegenerative disorders, particularly Alzheimers and Parkinsons disease, would improve the condition of several patients with neurological disorders. The importance of Wnt activators and modulators in patients with such illnesses is to mainly restore rather than overstimulate the Wnt/β-catenin signaling, thereby reestablishing the equilibrium between Wnt-OFF and Wnt-ON states. In this review, we have tried to summarize the significance of the Wnt canonical pathway in the pathophysiology of certain neurodegenerative diseases, such as Alzheimers disease, cerebral ischemia, Parkinsons disease, Huntingtons disease, multiple sclerosis, and other similar diseases, and as to how can it be restored in these patients.


  • Open Access

    Bioengineering Microbes for Improved Nutritional Value and Health Benefits.

    by Jatan Pandya, Rachana S Adiga, Akash K, Chadhmika C H, Niveditha K, Debasish Kar

    Microbe bioengineering has the potential to improve the nutritional value and health benefits of food products. Modifying microbial cells to produce specific proteins or compounds that can improve human health is one approach. Penicillin and recombinant insulin are two examples of this. The production of recombinant insulin by genetically modified E. coli bacteria has transformed diabetes treatment by providing a consistent and cost-effective source of insulin. Previously, insulin was extracted from the pancreas of animals, which was an expensive process that frequently resulted in impurities that could cause adverse reactions. Bioengineered insulin is now the standard diabetes treatment, providing a safe and effective method of controlling blood glucose levels. Bacteria, for example, can be genetically modified to produce vitamins like B12, which are difficult to obtain from plant sources. Likewise, yeasts can be genetically modified to produce β-carotene, a precursor to vitamin A that is required for vision, immune function, and skin health. Overall, bioengineered microorganisms have the potential to provide significant health benefits by producing essential compounds and proteins. Because of ongoing advances in genetic engineering techniques and understanding microbial metabolism, the possibilities for improving human health through bioengineering are limitless.


  • Open Access

    Breeding techniques to dispense higher genetic gains

    by Achala Anand, Madhumitha Subramanian, Debasish Kar

    Plant breeding techniques encompass all the processes aimed at improving the genetic characteristics of a crop. It helps in achieving desirable characteristics like resistance to diseases and pests, tolerance to environmental stresses, higher yield and improved quality of the crop. This review article aims to describe and evaluate the current plant breeding techniques and novel methods. This qualitative review employs a comparative approach in exploring the different plant breeding techniques. Conventional plant breeding techniques were compared with modern ones to understand the advancements in plant biotechnology. Backcross breeding, mass selection, and pure-line selection were all discussed in conventional plant breeding for self-pollination and recurrent selection and hybridisation were employed for cross-pollinated crops. Modern techniques comprise of CRISPR Cas-9, high-throughput phenotyping, marker-assisted selection and genomic selection. Further, novel techniques were reviewed to gain more insight. An in-depth analysis of conventional and modern plant breeding has helped gain insight on the advantages and disadvantages of the two. Modern breeding techniques have an upper hand as they are more reliable and less time consuming. It is also more accurate as it is a genotype-based method. However, conventional breeding techniques are cost effective and require less expertise. Modern plant breeding has an upper hand as it uses genomics techniques. Techniques like QTL mapping, marker assisted breeding aid in selection of superior plants right at the seedling stage, which is impossible with conventional breeding. Unlike the conventional method, modern methods are capable of selecting recessive alleles by using different markers. Modern plant breeding is a science and therefore more reliable and accurate.


  • Open Access

    Biochemical exploration of β-lactamase inhibitors

    by Varshaa Arer, Debasish Kar&Ast

    The alarming rise of microbial resistance to antibiotics has severely limited the efficacy of current treatment options. The prevalence of β-lactamase enzymes is a significant contributor to the emergence of antibiotic resistance. There are four classes of β-lactamases: A, B, C, and D. Class B is the metallo-β-lactamase, while the rest are serine β-lactamases. The clinical use of β-lactamase inhibitors began as an attempt to combat β-lactamase-mediated resistance. Although β-lactamase inhibitors alone are ineffective against bacteria, research has shown that combining inhibitors with antibiotics is a safe and effective treatment that not only prevents β-lactamase formation but also broadens the range of activity. These inhibitors may cause either temporary or permanent inhibition. The development of new β-lactamase inhibitors will be a primary focus of future research. This study discusses recent advances in our knowledge of the biochemistry behind β-lactam breakdown, with special emphasis on the mechanism of inhibitors for β-lactam complexes with β-lactamase. The study also focuses on the pharmacokinetic and pharmacodynamic properties of all inhibitors and then applies them in clinical settings. Our analysis and discussion of the challenges that exist in designing inhibitors might help pharmaceutical researchers address root issues and develop more effective inhibitors.